ArticleBrazilian dental journal2026
Antibiofilm activity of three-dimensional bacterial nanocellulose scaffolds containing antimicrobial agents.
Article in Brazilian dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent advances in bioengineering and functional applications of microbial biocomposites: integrating bacterial cellulose, fungal mycelium and synthetic biology.World journal of microbiology & biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Studies have focused on the use of alternative scaffolds for Regenerative Endodontic Procedures (REPs) because current materials still pose significant technical limitations. The purpose of this in vitro study was to evaluate the antibiofilm activity of three-dimensional bacterial nanocellulose (BNC) scaffolds incorporated with 0.12% chlorhexidine digluconate (BNC/CHX), 1% amoxicillin (BNC/AMOX), and 1% clindamycin (BNC/CLI). BNC scaffolds without an antimicrobial agent composed the control group (BNC/C). BNC scaffolds were immersed in a multispecies culture of E. faecalis, A. naeslundii, and S. sanguinis, which served as a substrate for biofilm growth. After 24 hours, 7, and 15 days, the mean value of colony-forming units (CFUs) was determined. Multispecies biofilm formation on the BNC scaffolds was assessed under Scanning Electron Microscopy (SEM) and Confocal Laser Scanning Microscopy (CLSM). For the biofilm cell viability test, the mean value of CFU/mL for each sample was determined, and the data were normalized by taking the base-10 logarithm (log10) of each CFU/mL value. Data were analyzed by Two-way ANOVA, followed by Bonferroni's post-hoc multiple comparisons (α=5%). In the 24h period, BNC/AMOX demonstrated significantly lower CFUs mean values than BNC/CHX, BNC/CLI, and BNC/C (p<0.05). CFUs mean values increased throughout the experimental periods, with no significant difference compared to the other groups (p>0.05). SEM and CLSM analysis revealed, in the initial periods, a lower number of microorganisms in the experimental groups compared to the control group. BNC scaffolds containing 1% amoxicillin and 1% clindamycin demonstrated greater antimicrobial activity against a multispecies biofilm within the initial periods of incubation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.